Studies have revealed that blocking the action of BET with siRNAs or its selective inhibitors, such as JQ1 and INCB057643, can increase DNA damage and impair the DDR in malignant diseases, such as ovarian cancer. The gene discussed is DNER; the disease is ovarian carcinoma.